[Drug induced hepatotoxicity in targeted therapy for lung cancer].

Zhongguo Fei Ai Za Zhi

Department of Medical Oncology, Affiliated Hangzhou Hospital (Hangzhou First People's Hospital), Nanjing Medical University, Hangzhou 310006, China.

Published: September 2014

Targeted drugs aimed at driver gene, such as Gefitinib, Erlotinib and Crizotinib, have an irreplaceable position in the therapy of advanced non-small cell lung cancer. These drugs bring benefit to patients, however, higher hepatotoxicity is also presented. Now, drug induced hepatotoxicity and its mechanism are reviewed.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000506PMC
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.09.08DOI Listing

Publication Analysis

Top Keywords

induced hepatotoxicity
8
[drug induced
4
hepatotoxicity targeted
4
targeted therapy
4
therapy lung
4
lung cancer]
4
cancer] targeted
4
targeted drugs
4
drugs aimed
4
aimed driver
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!